glyoxylate reductase/hydroxypyruvate reductase
| GO Term | Evidence Code | PMID |
|---|---|---|
| monocarboxylic acid metabolic process |
|
|
| dicarboxylic acid metabolic process |
|
|
| dicarboxylic acid metabolic process |
|
|
| glyoxylate metabolic process |
|
|
| glyoxylate metabolic process |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm |
|
|
| cytoplasm |
|
|
| cytosol |
|
|
| catalytic complex |
|
|
| catalytic complex |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| hydroxypyruvate reductase (NADH) activity |
|
|
| hydroxypyruvate reductase (NADH) activity |
|
|
| hydroxypyruvate reductase (NADH) activity |
|
|
| oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
|
|
| hydroxypyruvate reductase [NAD(P)H] activity |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111671 | primary hyperoxaluria type 2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026